Establishing the evidence base for maintaining biodiversity and ecosystem function in the oil palm landscapes of South East Asia

Por Foster, William A., Snaddon, Jake L., Turner, Edgar C., Fayle, Tom M., Cockerill, Timothy D., Ellwood, M. D. Farnon, Broad, Gavin R., Chung, Arthur Y. C., Eggleton, Paul, Khen, Chey Vun, Yusah, Kalsum M.
Publicado em 2011

Diagnosis Of The Chronic Lymphocytic Leukemia (CLL) Using A Raman-Based Scanner Optimized For Blood Smear Analysis (M3s Project)

Por M. Fere, L.H. Liu, C. Gobinet, A. Beljebbar, V. Untereiner, J.-F. Angiboust, M. Manfait, G. Gheldof, H. Jacquemin, S. Walbrecq, E. Cornet, X. Troussard, B. Chatelain, J. Angelo, M. Chollat, J. Klossa, O. Piot
Publicado em 2016-06-01

The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo- and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis.

Por Delic, J., Masdehors, P., Omura, S., Cosset, J. M., Dumont, J., Binet, J. L., Magdelénat, H.
Publicado em 1998

Using gene therapy to manipulate the immune system in the fight against B cell leukemias

Por Bouhassira, Diana CG, Thompson, Joshua J, Davila, Marco L
Publicado no Expert Opin Biol Ther (2015)

Mechanism for IL-15-driven B-CLL cycling: Roles for AKT and STAT5 in modulating Cyclin D2 and DNA damage response proteins (1)

Por Gupta, Rashmi, Li, Wentian, Yan, Xiao J, Barrientos, Jacqueline, Kolitz, Jonathan E., Allen, Steven L., Rai, Kanti, Chiorazzi, Nicholas, Mongini, Patricia K. A.
Publicado no J Immunol (2019)

A complementary role of multiparameter flow cytometry and high-throughput sequencing for minimal residual disease detection in chronic lymphocytic leukemia: an European Research Initiative on CLL study

Por Rawstron, A C, Fazi, C, Agathangelidis, A, Villamor, N, Letestu, R, Nomdedeu, J, Palacio, C, Stehlikova, O, Kreuzer, K-A, Liptrot, S, O'Brien, D, de Tute, R M, Marinov, I, Hauwel, M, Spacek, M, Dobber, J, Kater, A P, Gambell, P, Soosapilla, A, Lozanski, G, Brachtl, G, Lin, K, Boysen, J, Hanson, C, Jorgensen, J L, Stetler-Stevenson, M, Yuan, C, Broome, H E, Rassenti, L, Craig, F, Delgado, J, Moreno, C, Bosch, F, Egle, A, Doubek, M, Pospisilova, S, Mulligan, S, Westerman, D, Sanders, C M, Emerson, R, Robins, H S, Kirsch, I, Shanafelt, T, Pettitt, A, Kipps, T J, Wierda, W G, Cymbalista, F, Hallek, M, Hillmen, P, Montserrat, E, Ghia, P
Publicado no Leukemia (2016)

Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL

Por Slager, Susan L., Rabe, Kari G., Achenbach, Sara J., Vachon, Celine M., Goldin, Lynn R., Strom, Sara S., Lanasa, Mark C., Spector, Logan G., Rassenti, Laura Z., Leis, Jose F., Camp, Nicola J., Glenn, Martha, Kay, Neil E., Cunningham, Julie M., Hanson, Curtis A., Marti, Gerald E., Weinberg, J. Brice, Morrison, Vicki A., Link, Brian K., Call, Timothy G., Caporaso, Neil E., Cerhan, James R.
Publicado em 2011

The Ina and Inb blood group antigens are located on a glycoprotein of 80,000 MW (the CDw44 glycoprotein) whose expression is influenced by the In(Lu) gene.

Por Spring, F A, Dalchau, R, Daniels, G L, Mallinson, G, Judson, P A, Parsons, S F, Fabre, J W, Anstee, D J
Publicado em 1988

Biological Validation of Differentially Expressed Genes in Chronic Lymphocytic Leukemia Identified by Applying Multiple Statistical Methods to Oligonucleotide Microarrays

Por Abruzzo, Lynne V., Wang, Jing, Kapoor, Mini, Medeiros, L. Jeffrey, Keating, Michael J., Highsmith, W. Edward, Barron, Lynn L., Cromwell, Candy C., Coombes, Kevin R.
Publicado em 2005

Co-operative Membrane Disruption Between Cell-penetrating Peptide and Cargo: Implications for the Therapeutic Use of the Bcl-2 Converter Peptide D-NuBCP-9-r8

Por Watkins, Catherine L, Sayers, Edward J, Allender, Chris, Barrow, David, Fegan, Christopher, Brennan, Paul, Jones, Arwyn T
Publicado em 2011

Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy

Por Sinha, Sutapa, Boysen, Justin C., Chaffee, Kari G., Kabat, Brian F., Slager, Susan L., Parikh, Sameer A., Secreto, Charla R., Call, Tim, Shanafelt, Tait D., Leis, Jose F., Warner, Steven L., Bearss, David J., Ghosh, Asish K., Kay, Neil E.
Publicado no Oncotarget (2018)

Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia

Por Malcikova, J, Stano-Kozubik, K, Tichy, B, Kantorova, B, Pavlova, S, Tom, N, Radova, L, Smardova, J, Pardy, F, Doubek, M, Brychtova, Y, Mraz, M, Plevova, K, Diviskova, E, Oltova, A, Mayer, J, Pospisilova, S, Trbusek, M
Publicado no Leukemia (2015)

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol

Por Mahoney, Emilia, Lucas, David M., Gupta, Sneha V., Wagner, Amy J., Herman, Sarah E. M., Smith, Lisa L., Yeh, Yuh-Ying, Andritsos, Leslie, Jones, Jeffrey A., Flynn, Joseph M., Blum, Kristie A., Zhang, Xiaoli, Lehman, Amy, Kong, Hui, Gurcan, Metin, Grever, Michael R., Johnson, Amy J., Byrd, John C.
Publicado em 2012

Other Malignancies in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Por Tsimberidou, Apostolia-Maria, Wen, Sijin, McLaughlin, Peter, O'Brien, Susan, Wierda, William G., Lerner, Susan, Strom, Sara, Freireich, Emil J, Medeiros, L. Jeffrey, Kantarjian, Hagop M., Keating, Michael J.
Publicado no J Clin Oncol (2009)

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival sig...

Por Herman, Sarah E. M., Gordon, Amber L., Wagner, Amy J., Heerema, Nyla A., Zhao, Weiqiang, Flynn, Joseph M., Jones, Jeffrey, Andritsos, Leslie, Puri, Kamal D., Lannutti, Brian J., Giese, Neill A., Zhang, Xiaoli, Wei, Lai, Byrd, John C., Johnson, Amy J.
Publicado em 2010

A novel antibody–drug conjugate targeting SAIL for the treatment of hematologic malignancies

Por Kim, S Y, Theunissen, J-W, Balibalos, J, Liao-Chan, S, Babcock, M C, Wong, T, Cairns, B, Gonzalez, D, van der Horst, E H, Perez, M, Levashova, Z, Chinn, L, D‘Alessio, J A, Flory, M, Bermudez, A, Jackson, D Y, Ha, E, Monteon, J, Bruhns, M F, Chen, G, Migone, T-S
Publicado no Blood Cancer J (2015)

A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia

Por Sellick, Gabrielle S., Goldin, Lynn R., Wild, Ruth W., Slager, Susan L., Ressenti, Laura, Strom, Sara S., Dyer, Martin J. S., Mauro, Francesca R., Marti, Gerald E., Fuller, Stephen, Lyttelton, Matthew, Kipps, Thomas J., Keating, Michael J., Call, Timothy G., Catovsky, Daniel, Caporaso, Neil, Houlston, Richard S.
Publicado em 2007

Inferring clonal heterogeneity in cancer using SNP arrays and whole genome sequencing

Por Zucker, Mark R, Abruzzo, Lynne V, Herling, Carmen D, Barron, Lynn L, Keating, Michael J, Abrams, Zachary B, Heerema, Nyla, Coombes, Kevin R
Publicado no Bioinformatics (2019)

Trisomy 12 chronic lymphocytic leukemia expresses a unique set of activated and targetable pathways

Por Abruzzo, Lynne V., Herling, Carmen D., Calin, George A., Oakes, Christopher, Barron, Lynn L., Banks, Haley E., Katju, Vikram, Keating, Michael J., Coombes, Kevin R.
Publicado no Haematologica (2018)

Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia

Por Fraietta, Joseph A., Lacey, Simon F., Orlando, Elena J., Pruteanu-Malinici, Iulian, Gohil, Mercy, Lundh, Stefan, Boesteanu, Alina C., Wang, Yan, O’Connor, Roddy S., Hwang, Wei-Ting, Pequignot, Edward, Ambrose, David E., Zhang, Changfeng, Wilcox, Nicholas, Bedoya, Felipe, Dorfmeier, Corin, Chen, Fang, Tian, Lifeng, Parakandi, Harit, Gupta, Minnal, Young, Regina M., Johnson, F. Brad, Kulikovskaya, Irina, Liu, Li, Xu, Jun, Kassim, Sadik H., Davis, Megan M., Levine, Bruce L., Frey, Noelle V., Siegel, Donald L., Huang, Alexander C., Wherry, E. John, Bitter, Hans, Brogdon, Jennifer L., Porter, David L., June, Carl H., Melenhorst, J. Joseph
Publicado no Nat Med (2018)